Mitofilin Preservation Mitigates Cardiac Injury in Donation-After-Circulatory-Death Hearts
Cells · 18.05.2026 · 15 (10) · 920
DOI: 10.3390/cells15100920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 18.05.2026. Verfasst von Qun Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine, Division of Cardiology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Mitochondrial Proteins, Muscle Proteins. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merit Review Grants, Pauley Heart Center, The Thoracic Surgery Foundation Resident Research Fellowship Award.
Abstract (Originalsprache)
Donation after circulatory death (DCD) involves unavoidable ischemia–reperfusion injury (IRI). Mitochondrial permeability transition pore (MPTP) opening plays a critical role in DCD heart injury. Activation of ubiquitous calpains, including calpain-1 and calpain-2 (CPN1/2), increases MPTP opening in DCD hearts. Mitofilin, a mitochondrial inner membrane protein that regulates cristae morphology, is also involved in MPTP opening during ischemia–reperfusion. However, it remains unclear whether CPN1/2 activation contributes to mitofilin-mediated IRI in DCD hearts. We first incubated a mitofilin peptide with exogenous CPN1 in vitro to investigate the link between CPN1 activation and mitofilin degradation. Next, we tested whether CPN1/2 inhibition reduces cardiac injury in DCD hearts by preserving mitofilin and limiting MPTP opening. Sprague-Dawley (SD) rat hearts were subjected to 25 min of in vivo ischemia followed by ex vivo perfusion with or without the CPN1/2 inhibitor MDL-28170 (10 µM). In vitro incubation with CPN1 led to mitofilin degradation, confirming mitofilin as a CPN1 substrate. CPN1/2 inhibition significantly reduced infarct size compared with untreated DCD hearts, preserved mitofilin expression, and decreased MPTP opening. These findings indicate that CPN1/2 activation promotes MPTP opening in DCD hearts through mitofilin degradation. Timely inhibition of CPN1/2 represents a promising strategy to reduce cardiac injury and improve DCD heart function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine, Division of Cardiology, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Richmond Department of Veterans Affairs Medical Center, Richmond, VA 23249, USA.
ORCID-Profile: Qun Chen, Zachary Kiernan, Oluwatoyin Akande, Mohammed Quader
Förderung
- Merit Review Grants
- Pauley Heart Center
- The Thoracic Surgery Foundation Resident Research Fellowship Award
Zitieren
APA
Chen, Q., Kiernan, Z., Labate, G., Akande, O., Lesnefsky, E. J., & Quader, M. (2026). Mitofilin Preservation Mitigates Cardiac Injury in Donation-After-Circulatory-Death Hearts. Cells, 15(10), 920. https://doi.org/10.3390/cells15100920
Vancouver
Chen Q, Kiernan Z, Labate G, Akande O, Lesnefsky EJ, Quader M. Mitofilin Preservation Mitigates Cardiac Injury in Donation-After-Circulatory-Death Hearts. Cells. 2026;15(10):920. doi:10.3390/cells15100920
BibTeX
@article{Chen2026,
author = {Chen, Qun and Kiernan, Zachary and Labate, Gina and Akande, Oluwatoyin and Lesnefsky, Edward J and Quader, Mohammed},
title = {Mitofilin Preservation Mitigates Cardiac Injury in Donation-After-Circulatory-Death Hearts},
journal = {Cells},
year = {2026},
volume = {15},
number = {10},
pages = {920},
doi = {10.3390/cells15100920}
}
EUVIMED